Position in NVAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$152,170
+$27,449 QoQ
Shares Held
16,154
+5.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#146
of 263 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLSTATE CORP holds $63,475,982 across 75 Biotechnology names. NVAX ranks #68 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,006 | $10,931,039 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,878 | $4,288,708 | |
| 3 | RPRX |
Royalty Pharma plc
|
58,143 | $3,260,078 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
16,120 | $3,018,953 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,185 | $2,463,930 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
63,116 | $2,233,675 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
45,639 | $2,146,858 | |
| 8 | MRNA |
Moderna, Inc.
|
29,980 | $2,099,499 |
All Filings in NVAX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,170 | 16,154 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $124,721 | 15,322 | Shares | Sole | 2026-05-11 | |
| 2021-12-31 | $999,200 | 6,984 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $338,329 | 1,632 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $348,188 | 1,640 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||